Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota ecosystem is a complex, dynamic community of trillions of microorganisms, including bacteria, fungi, archaea, and viruses, that reside primarily in the large intestine (Source: Nature Reviews Microbiology, 2022). This ecological community functions as a "forgotten organ," performing vital roles in nutrient metabolism, the synthesis of essential vitamins like K and B12, and the maturation of the host's immune system (Source: NIH, 2023). It also provides colonization resistance against pathogens by competing for nutrients and attachment sites (Source: Cell, 2021). Dysbiosis, characterized by a loss of microbial diversity or an overgrowth of pathogenic species, is strongly associated with local gastrointestinal disorders like Clostridioides difficile infection and inflammatory bowel disease (Source: PubMed, 2021). Furthermore, imbalances in the gut microbiota are linked to systemic conditions such as obesity, type 2 diabetes, and even neurodegenerative diseases via the gut-brain axis (Source: Nature, 2020). Therapeutic strategies targeting this ecosystem range from broad-spectrum antibiotics and probiotics to advanced live biotherapeutic products (LBPs) and fecal microbiota transplantations (Source: FDA, 2023). These interventions, such as the recently approved Vowst and Rebyota, aim to restore homeostatic balance and enhance the production of bioactive metabolites like short-chain fatty acids (Source: Seres Therapeutics, 2023).
Restoration of microbial diversity and ecological balance to suppress pathogen overgrowth and modulate host physiological processes (Source: Nature Reviews Microbiology, 2022).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota ecosystem (GM) (GM).